advertisement
11.14 Investigational drugs; pharmacological experiments (17)
Showing records 1 to 17
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments22717 Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor γ gene transfer in mice
Yamanaka O; Miyazaki K; Kitano A; Saika S; Nakajima Y; Ikeda K
Investigative Ophthalmology and Visual Science 2009; 50: 187-193
23358 Rho-kinase, but not protein kinase C, is involved in generation of the spontaneous tone in the resting phase of the isolated pig iris sphincter muscle
Okano M; Uchikawa Y; Tanaka N; Mutoh J; Ohkura M; Hisa H; Yamamoto R
Current Eye Research 2009; 34: 177-183
22778 Study on the influence of the treatment with some newly synthesized antiglaucoma prostamides on the hematological parameters on rats
Udeanu DI; Mihele D; Cocu F; Caraene G; Vulturescu V; Iova D
Farmacia 2008; 56: 669-674
22905 Effect of WIN55, 212-2 on lowing rabbit IOP
Liu H; Wang W; Zhao J
Chinese Ophthalmic Research 2008; 26: 929-931
22619 The effect of the Rho-associated protein kinase inhibitor, HA-1077, in the rabbit ocular hypertension model induced by water loading
Fukunaga T; Ikesugi K; Nishio M; Sugimoto M; Sasoh M; Hidaka H; Uji Y
Current Eye Research 2009; 34: 42-47
22610 A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits
Stagni E; Privitera MG; Bucolo C; Leggio GM; Motterlini R; Drago F
British Journal of Ophthalmology 2009; 93: 254-257
22816 Effect of vasoactive drugs on visual functions and ocular hemodynamics in patients with primary open-angle glaucoma
Makashova NV; Kiseleva TN; Ronzina IA; Vasil'eva AE
Vestnik Oftalmologii 2008; 124: 55-59
22936 Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: Critical role of p38 MAPK activation
El-Remessy AB; Tang Y; Zhu G; Matragoon S; Khalifa Y; Liu EK; Liu J-Y; Hanson E; Mian S; Fatteh N
Molecular Vision 2008; 14: 2190-2203
23362 GABA agonists fail to protect the retina from ischemia-reperfusion injury
Traustason S; Eysteinsson T; Agnarsson BA; Stefánsson E
Experimental Eye Research 2009; 88: 361-366
22558 Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J; Alcon Anecortave Acetate for IOP Research Team
Archives of Ophthalmology 2009; 127: 173-178
22523 Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma
Egorov E; Ropo A; on behalf of the Investigators
European Journal of Ophthalmology 2009; 19: 214-222
22897 Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: Synthesis and biological activity
Feng Z; Hellberg MR; Sharif NA; McLaughlin MA; Williams GW; Scott D; Wallace T
Bio-organic and Medicinal Chemistry 2009; 17: 576-584
22896 Chroman-3-amides as potent Rho kinase inhibitors
Chen YT; Bannister TD; Weiser A; Griffin E; Lin L; Ruiz C; Cameron MD; Schurer S; Duckett D; Schroter T
Bioorganic and Medicinal Chemistry Letters 2008; 18: 6406-6409
22921 The pleiotropic effects of ethacrynic acid
Somberg JC; Molnar J
American Journal of Therapeutics 2009; 16: 102-104
23004 Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals
Neroev VV; Archipova MM; Bakeeva LE; Fursova AZ; Grigorian EN; Grishanova AY; Iomdina EN; Ivashchenko ZN; Katargina LA; Khoroshilova-Maslova IP
Biochemistry. Biokhimiia 2008; 73: 1317-1328
22796 Possibilities of applying cannabinoids' in the treatment of glaucoma
Nadolska K; Gos R
Klinika Oczna 2008; 110:-9 314-317
23365 Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Experimental Eye Research 2009; 88: 504-511
